Protalix Announces New Data on ELELYSO(TM) (taliglucerase alfa) Presented at the European Working Group on Gaucher Disease 2014 11th Meeting

CARMIEL, Israel, June 27, 2014 -- (Healthcare Sales & Marketing Network) -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (PLX.TA), announced today that new clinical data on ELELYSOTM (taliglucerase alfa) will be presented at the European Working Group on ... BiopharmaceuticalsProtalix BioTherapeutics, ELELYSO, taliglucerase alfa, Gaucher Disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news